Successfully raising €300 million
11th SPAC listing on Euronext’s markets in 2021
Amsterdam – 2 July 2021 – Euronext today congratulates Odyssey Acquisition S.A., a newly formed Special Purpose Acquisition Company (SPAC) focusing on the European Healthcare and TMT (technology, media and telecom) sectors, on its listing on Euronext Amsterdam (ticker code: ODYSY). It is the 11th SPAC listing on Euronext markets year to date.
Odyssey Acquisition intends to focus on the European Healthcare and TMT sectors, two highly innovative industries that are experiencing robust growth and transformation and represent a significant investment opportunity for the European public capital markets. Leveraging its extensive network, the SPAC will focus on companies within such sectors which are in large and growing sub-segments, with differentiated business models, supported by strong structural tailwinds and solid ESG credentials, and which can benefit from access to the European public capital markets.
The newly listed SPAC is sponsored by a team of investors with experience in deal-making know-how, as well as specific industry expertise. At opening, the Unit price was set at €10.00 per share. Odyssey Acquisition S.A. has successfully raised €300 million in its Private Placement and Listing on Euronext Amsterdam.
Michael Zaoui, Chairman of Odyssey Acquisition, said: “We are delighted to have partnered with a team of highly experienced and talented executives in establishing Odyssey Acquisition. We look forward to playing an active role in supporting and accelerating the development of promising European businesses, including through enhanced access to public capital markets and using our combined network and expertise."
About Odyssey AcquisitionOdyssey Acquisition is a special purpose acquisition company incorporated under the laws of the Grand Duchy of Luxembourg as a public limited liability company for the purpose of completing a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination with a business with principal operations in Europe, in the TMT or healthcare spaces. The company is sponsored by the Zaoui brothers together with Jean Raby, Olivier Brandicourt and Michel Combes.